Stocks Actavis Inc

More

  • Nov 22- Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter. The agreement is set to draw political ire in a U.S. presidential election year for Pfizer's decision to use the...

  • Nov 22- Pfizer Inc's and Allergan Plc's boards of directors were due to approve their merger agreement on Sunday, in the healthcare sector's largest ever deal, according to people familiar with the matter. The deal, valued at more than $150 billion, would involve Pfizer paying with 11.3 of its shares for each Allergan share, the people said. While the transaction...

  • *Allergan up; unlikely to be hit by tax inversion rule. *Nike jumps on buyback, boosts Dow. The S&P 500 ended its strongest week in almost a year, while the Dow Jones industrial average erased its year-to-date loss, led by a 5.46 percent jump in Nike, which announced a $12 billion share buyback and a 2- for-1 share split.

  • *Allergan up; unlikely to be hit by tax inversion rule. *Nike jumps on buyback, boosts Dow. The Dow Jones industrial average briefly turned positive for the year, led by a 4.76 percent rise in Nike which announced a $12 billion share buyback and a 2- for-1 share split.

  • *Allergan up; unlikely to be hit by tax inversion rule. *Nike jumps on buyback; boosts Dow. The Dow Jones industrial average turned positive for the year, led by a 4.8 percent rise in Nike which announced a $12 billion share buyback and a 2- for-1 share split.

  • *Allergan rises; biggest influence on S&P. *Nike jumps on buyback; boosts Dow. The Dow Jones industrial average turned positive for the year, led by a 4.6 percent rise in Nike which announced a $12 billion share buyback and a 2- for-1 share split.

  • WASHINGTON/ NEW YORK, Nov 19- The U.S. Treasury Department on Thursday took steps to clamp down on tax-avoiding "inversion" deals with new rules, though there was scarce evidence they would stop the biggest inversion of them all, between Pfizer Inc and Allergan Plc. The $150 billion proposed deal, still under negotiation, would see New York- based Pfizer redomicile in...

  • WASHINGTON, Nov 19- The U.S. Treasury Department on Thursday clamped down on tax-avoiding "inversion" deals that U.S. companies do with foreign corporations. It was not immediately clear if the new rules would affect drug maker Pfizer Inc's roughly $150 billion bid for smaller Irish rival Allergan Plc. The combination of New York- based Pfizer, which makes Viagra,...

  • WASHINGTON, Nov 19- The U.S. Treasury Department on Thursday clamped down on tax-avoiding "inversion" deals that U.S. companies do with foreign corporations. It was not immediately clear if the new rules would affect Pfizer Inc's bid for rival Allergan Plc. "While we intend to take additional action in the coming months, there is only so much the Treasury Department...

  • Nov 19- Several large U.S. funds that boosted their stakes in Allergan Plc in recent months appear to be optimistic about the company's growth prospects, even before Pfizer's reported $150 billion takeover bid for the botox maker. Pfizer Inc is negotiating to buy Allergan, which also makes dry eye treatments, for $370 to $380 per share, a person familiar with the...

  • Nov 19- Several large U.S. funds that boosted their stakes in Allergan Plc in recent months appear to be optimistic about the company's growth prospects, even before Pfizer's reported $150 billion takeover bid for the botox maker. Pfizer Inc is negotiating to buy Allergan, which also makes dry eye treatments, for $370 to $380 per share, a person familiar with the...

  • *UnitedHealth falls after results, biggest drag on Dow. *Intel rallies after dividend hike. Nov 19- Wall Street wobbled on Thursday as healthcare stocks ended a three-day rally after UnitedHealth cut its profit forecast, offsetting gains in Intel and other technology stocks.

  • Nov 19- Pfizer Inc is negotiating a break-up fee in the range of 2 to 3 percent of the value of its roughly $150 billion potential acquisition of Allergan Plc, proportionally in line with other deals, people familiar with the matter said. A break-up fee of that amount, to be paid by Pfizer if it were to walk away from the Allergan deal, would show confidence that the...

  • *Best Buy, UnitedHealth fall after results. Nov 19- U.S. indexes wobbled on Thursday as healthcare stocks snapped a three-day rally after UnitedHealth cut its profit forecast, offsetting gains in technology and consumer stocks. Dow component UnitedHealth fell 4 percent to $112.49.

  • *Best Buy, UnitedHealth fall after results. Nov 19- Wall Street wobbled in early trading on Thursday as healthcare stocks snapped a three-day rally after UnitedHealth cut its profit forecast for the year. Dow component UnitedHealth fell 5.6 percent to $110.73.

  • Nov 19- Pfizer Inc and Allergan Plc are in final stages of talks over an all-stock deal, CNBC tweeted, citing sources. Reuters reported on Wednesday that Pfizer's talks to acquire Allergan had accelerated, as the U.S. Pfizer will offer more than 11 shares for each Allergan share held, CNBC said on Thursday.

  • *Best Buy, UnitedHealth fall after results. *Keurig Green Mountain, Salesforce up on results. "This week, the bulls are back in control of the market and we've almost recovered, if not on track to recover, all of last week's losses and then some," said Adam Sarhan, chief executive of Sarhan Capital in New York.

  • NEW YORK/ WASHINGTON, Nov 18- Pfizer Inc's talks to acquire Allergan Plc in a $150 billion deal that would see the U.S. drug giant redomicile in Ireland accelerated on Wednesday, as the U.S. Pfizer is negotiating a price of $370 to $380 for each Allergan share, a person familiar with the discussions said, asking not to be identified because the talks are confidential.

  • Nov 18- Pfizer Inc is in talks to acquire Allergan Plc for $370- $380 per share, according to a person familiar with the matter, valuing the potential deal at around $150 billion, the healthcare sector's biggest. Talks between the sides have accelerated, though the U.S. Pfizer declined to comment, while Allergan did not respond to a request for comment.

  • *Fairchild Semiconductor up after buyout offer. Apple's shares were up 3 percent at $117.07 after Goldman Sachs added the iPhone maker to its "conviction buy" list, saying it sees potential for the stock gaining as much as 43 percent from current levels. "All eyes are on the Fed, while geopolitical concerns remain on the minds of the investors," said Peter Cardillo,...